Abstracts Archive - Page 1155 of 2425 - ACR Meeting Abstracts

Abstract Number: 2257 • 2018 ACR/ARHP Annual Meeting
Prevalence and Distinct Clinical Phenotype of Concomitant Sarcoidosis in Other Autoimmune Rheumatic Diseases
Kristina E.N. Clark¹, Huw Beynon², Christopher P. Denton³ and Voon H. Ong⁴, ¹Centre of Rheumatology and Connective Tissue Diseases, University College London, London, United Kingdom, ²Department of Rheumatology, Royal Free Hospital, London, United Kingdom, ³UCL Division of Medicine, Royal Free Campus, London, United Kingdom, ⁴Division of Medicine, University College London, London, United Kingdom
Background/Purpose: Lung involvement is common in both sarcoidosis (up to 90%) and autoimmune rheumatic diseases (ARDs). Case reports have suggested distinct clinical manifestations when sarcoidosis…
Abstract Number: 2258 • 2018 ACR/ARHP Annual Meeting
Defining Characteristics of Patients with Overlap between Sarcoidosis and Connective Tissue Diseases
Mugdha Agrawal and Colin Ligon, Department of Medicine; Division of Rheumatology, University of Pennsylvania, Philadelphia, PA
Background/Purpose: Sarcoidosis has been suggested to occur with connective tissue diseases (CTDs) more frequently than would be expected by chance, but the types, relative…
Abstract Number: 2259 • 2018 ACR/ARHP Annual Meeting
BONE Sarcoidosis: A French Case Control Study
Imen Ben hassine¹, Christopher Rein², Cloé Comarmond³, Catherine Chapelon-Abric⁴, Nathalie Saidenberg⁵, Benoit Meunier⁶, Nicolas Schleinitz⁷, Noémie Chanson⁸, Marc Scherlinger⁹, Christophe Richez¹⁰, Sandrine Hirschi¹¹, Matthieu Groh¹², Hervé Devilliers¹³, David Saadoun¹⁴, Laurent Arnaud¹⁵ and Patrice Cacoub¹⁶, ¹Internal Medicine and Clinical Immunology, Pitié-Salpêtrière Hospital, Paris, France, ²Rheumatology, UPMC GRC08, Paris 06 University, Pitié Salpétrière Hospital, Paris, France, ³DHU 2iB Internal Medicine Referal Center for Autoimmune diseases Pitie Hospital, Paris, France, ⁴AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, F-75013, Paris, France, Paris, France, ⁵Rheumatology, CHU Avicennes, Bobigny, France, ⁶Internal Medicine, CHU La Timone, Marseille, France, ⁷La Timone University Hospital, Marseille, France, ⁸Internal Medicine, Hopital Bicetre, LE KREMLIN BICETRE, France, ⁹Rheumatology, UMR CNRS 5164 - Immunoconcept, France, Bordeaux, France, ¹⁰UMR CNRS 5164 - Immunoconcept, Bordeaux, France, ¹¹Pneumology, CHU de Strasbourg, Strasbourg, France, ¹²Internal Medicine, Foch, Suresnes, France, ¹³Service de Médecine Interne et Maladies Systémiques, CHU de Dijon, Dijon, France, ¹⁴Sorbonne Universités, UPMC Univ Paris 06, UMR 7211, and Inflammation-Immunopathology-Biotherapy Department (DHU i2B), F-75005, Paris, France; INSERM, UMR_S 959, F-75013, Paris, France; CNRS, FRE3632, F-75005, Paris, France; AP-HP, Groupe Hospitalier Pitié, Paris, France, ¹⁵Department of Medicine, Rheumatology Unit, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden, ¹⁶Department of Internal Medicine and Clinical Immunology, Groupe Hospitalier Pitié-Salpêtrière, Paris, France
Background/Purpose: Osseous manifestations of sarcoidosis are uncommon. We aimed to characterize clinical presentation, distribution of lesions, treatment, and outcomes of bone sarcoidosis. Methods: A French…
Abstract Number: 2260 • 2018 ACR/ARHP Annual Meeting
Musculoskeletal Sarcoidosis: A 15-Year Experience from a Tertiary Care Center in the US
Sanjeev Patil¹, Masumi Arakane², Sreedevi Jenigiri³, Elizabeth Field⁴ and Namrata Singh⁵, ¹Rheumatology, University of Iowa Hospitals and Clinics, Iowa City, IA, ²University of Iowa Hospitals and Clinics, Iowa City, IA, ³Iowa City VA Healthcare System, Iowa City, IA, ⁴Iowa City VA, Iowa City, IA, ⁵Internal Medicine, Iowa City VA Medical Center and University of Iowa, Iowa City, IA
Background/Purpose: Sarcoidosis, a systemic disease characterized by non-caseating granulomas within the affected organs. Less than 10% of cases manifest as musculoskeletal (MSK) involvement of joints,…
Abstract Number: 2261 • 2018 ACR/ARHP Annual Meeting
Long-Term Outcome of Pulmonary Sarcoidosis: A Population-Based Cohort Study from 1976-2013
Patompong Ungprasert^1,2, Cynthia S. Crowson³, Eva M. Carmona Porquera⁴ and Eric L. Matteson⁵, ¹Clinical Epidemiology Unit, Department of Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, ²Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN, ³Health Sciences Research, Mayo Clinic College of Medicine and Science, Rochester, MN, ⁴Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN, ⁵Division of Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN
Long-term Outcome of Pulmonary Sarcoidosis: A Population-Based Cohort Study from 1976-2013 Background/Purpose: A hallmark of sarcoidosis is lung disease, which has variable expression. This study…
Abstract Number: 2262 • 2018 ACR/ARHP Annual Meeting
Increased Risk of Sarcoidosis Among Patients with Celiac Disease: A Systematic Review and Meta-Analysis
Patompong Ungprasert¹, Karn Wijarnpreecha², Panadeekarn Panjawatanan³, Ploypin Lertjitbanjong² and Juan Corral⁴, ¹Clinical Epidemiology Unit, Department of Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, ²Internal medicine, Bassett medical center, cooperstown, NY, ³Medicine, Chiang Mai University, Chiang Mai, Thailand, ⁴Internal medicine, Mayo Clinic, Jacksonville, Jacksonville, FL
Increased Risk of Sarcoidosis among Patients with Celiac Disease: A Systematic Review and Meta-Analysis AbstractBackground/Purpose: Several epidemiologic studies have suggested that patients with celiac disease may…
Abstract Number: 2263 • 2018 ACR/ARHP Annual Meeting
Differentiated Phenotypes at Diagnosis of Sarcoidosis According to the Scadding Classification: Analysis in 1230 Patients
Soledad Retamozo^1,2,3, Roberto Pérez-Alvarez⁴, Pilar Brito-Zerón^5,6, Belchin Kostov⁷, Carlos Feijoo Massó⁸, Guadalupe Fraile⁹, A. González-García¹⁰, Ricardo Gómez De La Torre¹¹, Begoña De-Escalante¹², Miguel Lopez-Dupla¹³, Ana Alguacil¹⁴, Joel Chara-Cervantes¹⁵, M. Pérez-Conesa¹⁶, Francisco-Javier Rascón¹⁷, Jose Salvador Garcia Morillo¹⁸, Patricia Perez Guerrero¹⁹, Eva Fonseca Aizpuru²⁰, Miriam Akasbi²¹, Mariona Bonet²², José Luis Callejas²³, Gloria De La Red Bellvis²⁴, Eva Calvo Begueria²⁵, Cristina Soler i Ferrer²⁶, Enrique Peral Gutiérrez De Ceballos²⁷, J. F. Gómez-Cerezo²⁸, Gracia Cruz Caparrós²⁹, Sergio Rodríguez Fernández³⁰, Blanca Pinilla³¹, Alberto Gato Diez³², A. Rolo³³, César Morcillo⁶, Angel Robles³⁴, Inmaculada Ojeda³⁵, M. J. Vives³⁶, Borja de-Miguel³⁷, María Penadés Vidal³⁸, Moisés De Vicente³⁹, Xavier Bosh⁴⁰, Marta Pérez-de-Lis⁴¹, A. González-García⁹, Carmen Yllera Gutiérrez⁴², B. Gracia-Tello⁴³, M. Pedrosa⁴⁴, A. Perez-Gonzalez⁴, Carles Tolosa⁴⁵, Antoni Sisó-Almirall⁴⁶, Lucio Pallarés⁴⁷ and Manuel Ramos-Casals⁵, ¹Instituto de Investigaciones en Ciencias de la Salud, Universidad Nacional de Córdoba, Consejo Nacional de Investigaciones Científicas y Técnicas (INICSA-UNC-CONICET), Cordoba, Argentina, ²Laboratory of Systemic Autoimmune Diseases “Josep Font”, CELLEX, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Department of Systemic Autoimmune Diseases, ICMID, Hospital Clinic, Barcelona, Barcelona, Spain, ³Rheumatology Unit, Hospital Privado Universitario de Córdoba, Institute University of Biomedical Sciences University of Córdoba (IUCBC), Cordoba, Argentina, ⁴Department of Internal Medicine, Hospital Alvaro Cunqueiro, Vigo, Vigo, Spain, ⁵Laboratory of Autoimmune Diseases Josep Font, IDIBAPS, Department of Autoimmune Diseases, ICMiD, Hospital Clinic, Barcelona, Barcelona, Spain, ⁶Systemic Autoimmune Diseases Unit, Hospital CIMA-Sanitas, Barcelona, Barcelona, Spain, ⁷Primary Care Research Group, IDIBAPS, Centre d’Assistència Primària ABS Les Corts, GESCLINIC, Barcelona, Barcelona, Spain, ⁸Department of Internal Medicine, Hospital Parc Taulí, Sabadell, Sadabell, Spain, ⁹Hospital Ramon y Cajal, Madrid, Madrid, Spain, ¹⁰Internal Medicine, Hospital Ramón y Cajal, Madrid, Madrid, Spain, ¹¹Department of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, Oviedo, Spain, ¹²Hospital Clínico, Zaragoza, Zaragoza, Spain, ¹³Systemic Autoimmune Diseases Unit, Hospital Joan XXIII, Tarragona, Tarragona, Spain, ¹⁴Hospital Virgen de la Salud, Toledo, Toledo, Spain, ¹⁵Hospital Universitario Miguel Servet, Zaragoza, Zaragoza, Spain, ¹⁶Hospital Miguel Servet, Zaragoza, Zaragoza, Spain, ¹⁷Hospital Son Espases, Palma de Mallorca, Palma de Mallorca, Spain, ¹⁸Department of Internal Medicine, Hospital Virgen del Rocio, Sevilla, Sevilla, Spain, ¹⁹Department of Internal Medicine, Hospital Universitario Puerta del Mar, Cádiz, Cadiz, Spain, ²⁰Department of Internal Medicine, Hospital de Cabueñes, Gijón, Gijón, Spain, ²¹Department of Internal Medicine, Hospital Infanta Leonor, Madrid, Madrid, Spain, ²²Department of Internal Medicine, Althaia, Xarxa Assistencial de Manresa, Manresa, Spain, ²³Hospital Clínico San Cecilio, Granada, Granada, Spain, ²⁴Department of Internal Medicine, Hospital de Santa Coloma de Gramanet, Barcelona, Barcelona, Spain, ²⁵Hospital Universitario Puerta del Mar, Cádiz, Cádiz, Spain, ²⁶Hospital de Sta Caterina, Girona, Girona, Spain, ²⁷Department of Internal Medicine, Hospital Virgen Macarena, Sevilla, Sevilla, Spain, ²⁸Hospital Infanta Sofía, Madrid, Madrid, Spain, ²⁹Department of Internal Medicine, Hospital de Poniente El Ejido, Almería, Almería, Spain, ³⁰Department of Internal Medicine, Hospital da Barbanza, A Coruña, A Coruña, Spain, ³¹Systemic Autoimmune Diseases Unit Medicine, Hospital Gregorio Marañón, Madrid, Madrid, Spain, ³²Department of Internal Medicine, Complejo Hospitalario Albacete, Albacete, Albacete, Spain, ³³Hospital Salamanca, Salamanca, Salamanca, Spain, ³⁴Hospital La Paz, Madrid, Madrid, Spain, ³⁵Department of Internal Medicine, Hospital Valle del Guadiato, Córdoba, Cordoba, Spain, ³⁶Parc Sanitari San Joan de Déu, Sant Boi, Barcelona, Spain, ³⁷Hospital 12 de Octubre, Madrid, Madrid, Spain, ³⁸Department of Internal Medicine, Hospital De Manises, Valencia, Valencia, Spain, ³⁹Department of Internal Medicine, Hospital Nuestra Señora del Prado, Talavera, Talavera, Spain, ⁴⁰Department of Internal Medicine, ICMiD, Hospital Clinic, Barcelona, Barcelona, Spain, ⁴¹Servicio de Anestesiologia y Reanimación. Complejo Hospitalario Universitario de A Coruña, A Coruña, A Coruña, Spain, ⁴²Hospital Universitario Central de Asturias, Oviedo, Oviedo, Spain, ⁴³Hospital Clinico, Zaragoza, Zaragoza, Spain, ⁴⁴Hospìtal Parc Taulí, Sadabell, Sabadell, Spain, ⁴⁵Department of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí, Barcelona, Spain, ⁴⁶Grup de Recerca Transversal en Atenció Primària, IDIBAPS, Barcelona, Barcelona, Spain, ⁴⁷Department of Internal Medicine, Hospital Son Espases. Palma de Mallorca, Palma de Mallorca, Spain
Background/Purpose: To analyse the correlation between Scadding radiological stages and the main phenotypic features at diagnosis (epidemiology, clinical patterns at presentation, extrathoracic disease and need…
Abstract Number: 2264 • 2018 ACR/ARHP Annual Meeting
Methotrexate in the Treatment of Granulomatous Mastitis: A Retrospective Review of 19 Cases
Anna Postolova¹ and Mark C. Genovese², ¹Department of Medicine, Stanford University Medical Center, Palo Alto, CA, ²Department of Medicine, Stanford University, Palo Alto, CA
Background/Purpose: Granulomatous Mastitis is a rare, inflammatory disease of the breast. Presenting symptoms in the breast can be unilateral or bilateral pain, masses, skin induration,…
Abstract Number: 2265 • 2018 ACR/ARHP Annual Meeting
Lymphocyte Immunophenotyping and CD4/CD8 Ratio in Cerebrospinal Fluid for the Diagnosis of Sarcoidosis-Related Uveitis
Romain Paule¹, Laure Denis¹, Nicolas Chapuis², Julien Rohmer¹, Jonathan London³, Clemence Bonnet⁴, Anthony Chauvin⁵, Luc Mouthon¹, Dominique Monnet⁴, Claire Le Jeunne¹, Antoine Brezin⁶ and Benjamin Terrier⁷, ¹National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, Internal medicine, France, Paris, France, ²Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, Biological Hematology, France, Paris, France, ³Internal Medecine, National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, France, ⁴Referral Center for Rare Ophthalmological Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, ophtalmology, France, Paris, France, ⁵Emergency Département, Hôpital Lariboisière, Assistance Publique-Hôpitaux de Paris, Paris, France; Faculté de Médecine, Université Diderot, Paris, France, Paris, France, ⁶Ophtalmology, Referral Center for Rare Ophthalmological Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, ophtalmology, France, Paris, France, ⁷Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, France
Background/Purpose: The diagnostic workup of uveitis is a challenge due to the wide range of diagnoses and the lack of a well-codified diagnostic procedure. Underlying…
Abstract Number: 2266 • 2018 ACR/ARHP Annual Meeting
Serum 1,25(OH)2 Vitamin D and 25(OH) Vitamin D Ratio for the Diagnosis of Sarcoidosis-Related Uveitis
Julien Rohmer¹, Jérôme Hadjadj², Amina Bouzerara³, Sawsen Salah⁴, Romain Paule⁵, Matthieu Groh⁶, Philippe Blanche⁷, Luc Mouthon⁸, Dominique Monnet⁴, Claire Le Jeunne⁹, Jean Guibourdenche¹⁰, Antoine Brezin¹¹ and Benjamin Terrier¹², ¹National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, Internal medicine, France, Paris, France, ²Department of Internal Medicine, National Referral Center for Rare Autoimmune and Systemic Diseases, Hospital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), Team Neutrophils and Vasculitis, INSERM U1016, Cochin Institute, Paris, France, Paris, France, ³Service d'Hormonologie, Hôpital Cochin, Paris, France, ⁴Ophtalmology, Cochin Hospital, Paris, France, ⁵Department of Internal Medicine, Department of Internal Medicine, Cochin University Hospital, Paris, France, ⁶Internal Medicine, Foch, Suresnes, France, ⁷Internal Medicine, Cochin Hospital, Paris, France, ⁸Department of Internal Medicine, INSERM Unité 1016, Centre de Référence pour les Maladies Auto-immunes Rares, National Referral Center for Rare Systemic Autoimmune Diseases, Paris Cochin, France, Paris, France, ⁹Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, France, ¹⁰Hormonology department, Cochin Hospital, Paris, France, ¹¹Ophtalmology, Referral Center for Rare Ophthalmological Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, ophtalmology, France, Paris, France, ¹²National Referral Center for Rare Systemic Autoimmune Diseases, Paris Cochin, France, Paris, France
Background/Purpose: The diagnostic workup of uveitis is challenging, with 30 to 50% of cases remaining of undetermined etiology despite multiple investigations. Sarcoid granuloma-related increase of…
Abstract Number: 2267 • 2018 ACR/ARHP Annual Meeting
Ocular and Systemic Features in 262 Patients with Systemic Sarcoidosis and Its Correlation with Iwos Criteria
Belén Atienza-Mateo¹, José Luis Martín-Varillas¹, Rosalía Demetrio-Pablo², Vanesa Calvo-Río³, Diana Prieto Peña³, Monica Calderón Goercke³, Javier Rueda-Gotor¹, Enar Pons¹, Miguel Angel González-Gay² and Ricardo Blanco¹, ¹Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ²Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ³Rheumatology, Rheumatology. Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain
Background/Purpose: Sarcoidosis is a multisystemic inflammatory disease of unknown origin characterized by non-caseating epitheliod granulomas that can affect any organ system. The three most frequency…
Abstract Number: 2268 • 2018 ACR/ARHP Annual Meeting
Anti-IL6-Receptor Tocilizumab in Graves’ Orbitopathy. Multicenter Study of 46 Patients
Belén Atienza-Mateo¹, José Luis Martín-Varillas¹, Vanesa Calvo-Río², Rosalía Demetrio-Pablo³, Diana Prieto Peña², Monica Calderón Goercke², Elia Valls-Pascual⁴, Beatriz Valls-Espinosa⁵, Olga Maiz-Alonso⁶, Ana Blanco⁷, Ignacio Torre-Salaberri⁸, Verónica Rodriguez-Mendez⁹, Angel Garcia-Aparicio¹⁰, Raúl Veroz González¹¹, Vega Jovaní¹², Diana Peiteado¹³, Margarita Sanchez Orgaz¹⁴, Santos Castañeda¹⁵, Eva Tomero¹⁶, Francisco J. Toyos Sáenz de Miera¹⁷, Valvanera Pinillos¹⁸, Elena Aurrecoechea¹⁹, Ángel Mora²⁰, Arantxa Conesa²¹, Manuel Fernández²², Nuria Avilés²³, J. Antonio Troyano²⁴, Miguel Angel González-Gay¹ and Ricardo Blanco¹, ¹Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ²Rheumatology, Rheumatology. Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ³Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ⁴Hospital Universitario Doctor Peset. Valencia. Spain, Valencia, Spain, ⁵Rheumatology, Hospital Universitario Doctor Peset. Valencia. Spain, Valencia, Spain, ⁶Hospital Universitario Donostia. San Sebastian. Spain, Donostia, Spain, ⁷Ophtamology, Hospital Universitario Donostia. San Sebastian. Spain, San Sebastian, Spain, ⁸Rheumatology, Hospital Universitario de Basurto. Bilbao. Spain, Bilbao, Spain, ⁹Ophthalmology, Hospital Universitario de Basurto. Bilbao. Spain, Bilbao, Spain, ¹⁰Rheumatology, Hospital de Toledo. Toledo. Spain, Toledo, Spain, ¹¹Rheumatology, Hospital de Mérida. Badajoz. Spain, Mérida, Spain, ¹²Rheumatology, Hospital General Universitario de Alicante. Spain, Alicante, Spain, ¹³Rheumatology, Rheumatology, La Paz University Hospital, Madrid, Spain, ¹⁴Ophthalmology, Hospital Universitario La Paz. Madrid. Spain, Madrid, Spain, ¹⁵Rheumatology, Hospital La Princesa. Madrid. Spain, Madrid, Spain, ¹⁶Rheumatology, Hospital de La Princesa. Madrid. Spain, Madrid, Spain, ¹⁷Hospital Virgen de La Macarena. Sevilla. Spain, Sevilla, Spain, ¹⁸Rheumatology, Hospital San Pedro. Logroño. La Rioja. Spain, Logroño, Spain, ¹⁹Rheumatology, Hospital de Sierrallana. Torrelavega. Spain, Torrelavega, Spain, ²⁰Ophthalmology, Hospital de Sierrallana. Torrelavega. Cantabria. Spain, Torrelavega, Spain, ²¹Rheumatology, Hospital Clínico Universitario de Valencia. Spain, Valencia, Spain, ²²Hospital Universitario de Guadalajara. Spain, Guadalajara, Spain, ²³Rheumatology, Hospital Puerta del Mar. Cádiz. Spain, Cádiz, Spain, ²⁴Ophthalmology, Hospital Universitario Clínico San Carlos. Madrid. Spain, Madrid, Spain
Background/Purpose: To assess the efficacy of Tocilizumab (TCZ) in refractory thyroid associated orbitopathy (TAO) due to Grave’s disease.Methods: Multicenter study of 46 patients with TAO…
Abstract Number: 2269 • 2018 ACR/ARHP Annual Meeting
Infliximab Therapy in Refractory Retinal Vasculitis of Behçet’s Disease, Short and Long-Term Follow-up. Multicenter Study of 72 Patients
José Luis Martín-Varillas¹, Belén Atienza-Mateo¹, Vanesa Calvo-Río², Diana Prieto Peña², Monica Calderón Goercke², Rosalía Demetrio-Pablo³, Javier Loricera³, M. Victoria Hernández⁴, Alfredo Adan⁵, Marina Mesquida⁵, Diana Peiteado⁶, David Diaz-Valle⁷, Lucía Martínez-Costa⁸, Elia Valls-Pascual⁸, Miguel A. Caracuel⁹, Angel Garcia-Aparicio¹⁰, Jose M Herreras¹¹, Miguel Cordero-Coma¹², Carlos Alberto Montilla-Morales¹³, Alejandro Fonollosa¹⁴, Antonio Atanes¹⁵, Félix Francisco¹⁶, Ignacio Torre-Salaberri¹⁷, Olga Maíz¹⁸, Ana Blanco¹⁹, Cruz Fernandez-Espartero²⁰, Norberto Ortego Centeno²¹, Enrique Raya Álvarez²², Myriam Gandía²³, Francisco Javier López Longo²⁴, Maria Alcalde-Villar²⁵, Cristina Fernández-Carballido²⁶, Esperanza Pato Cour²⁷, Oscar Ruiz Moreno²⁸, Fernando Jiménez-Zorzo²⁹, Raquel Almodóvar González³⁰, Carmen Carrasco-Cubero³¹, Luis Francisco Linares³², Fredeswinda I. Romero-Bueno³³, Santos Insua³⁴, Senen González-Suárez³⁵, Marisa Hernández³⁶, Emma Beltrán³⁷, Juan Cruz³⁸, Carlos Férnandez Cid³⁹, Elena Aurrecoechea⁴⁰, Enar Pons¹, Miguel Angel González-Gay³ and Ricardo Blanco¹, ¹Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ²Rheumatology, Rheumatology. Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ³Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ⁴Rheumatology, Hospital Clinic. Barcelona. Spain, Barcelona, Spain, ⁵Hospital Clinic. Barcelona. Spain, Barcelona, Spain, ⁶Rheumatology, Rheumatology, La Paz University Hospital, Madrid, Spain, ⁷Hospital Clínico San Carlos. Madrid. Spain, Madrid, Spain, ⁸Hospital Universitario Doctor Peset. Valencia. Spain, Valencia, Spain, ⁹Hospital de Córdoba, Córdoba, Spain., Córdoba, Spain, ¹⁰Rheumatology, Hospital de Toledo. Toledo. Spain, Toledo, Spain, ¹¹Ophthalmology, Hospital Universitario, IOBA. Valladolid. Spain, Valladolid, Spain, ¹²Ophthalmology, Hospital de León. Spain, León, Spain, ¹³Hospital Clínico Universitario de Salamanca. Spain, Salamanca, Spain, ¹⁴Ophthalmology, Hospital de Cruces. Bilbao. Spain, Bilbao, Spain, ¹⁵Complejo Hospitalario Universitario A Coruña. Spain, A Coruna, Spain, ¹⁶Rheumatology, Hospital Doctor Negrín. Las Palmas de Gran Canaria. Spain, Las Palmas de Gran Canaria, Spain, ¹⁷Rheumatology, Hospital Universitario de Basurto. Bilbao. Spain, Bilbao, Spain, ¹⁸Hospital Universitario Donostia. San Sebastian. Spain, San Sebastián, Spain, ¹⁹Ophtamology, Hospital Universitario Donostia. San Sebastian. Spain, San Sebastian, Spain, ²⁰Rheumatology, Hospital de Móstoles. Madrid. Spain, Madrid, Spain, ²¹Medicine Department, Hospital Universitario San Cecilio. Granada. Spain, Granada, Spain, ²²Rheumatology, Hospital Universitario San Cecilio. Granada. Spain, Granada, Spain, ²³Rheumatology, Hospital Puerta del Mar. Cádiz. Spain, Cádiz, Spain, ²⁴Rheumatology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain, ²⁵Hospital Severo Ochoa, Madrid, Spain, Madrid, Spain, ²⁶Rheumatology Division, Hospital General Universitario de Elda, Elda, Spain, ²⁷Rheumatology, Hospital Clínico San Carlos, Madrid, Spain, ²⁸Ophthalmology and Rheumatology, Hospital Miguel Servet. Zaragoza. Spain, Zaragoza, Spain, ²⁹Hospital Miguel Servet. Zaragoza. Spain, Zaragoza, Spain, ³⁰Rheumatology, Hospital Universitario Fundación Alcorcón. Madrid. Spain, Madrid, Spain, ³¹Hospital de Mérida. Spain, Mérida, Spain, ³²Rheumatology, Hospital Virgen de la Arrixaca. Murcia. Spain, Murcia, Spain, ³³Section for Autoimmune Diseases, Rheumatology, Fundación Jiménez Díaz University Hospital & Health Research Institute, Madrid, Spain, ³⁴Rheumatology, Hospital Universitario Santiago de Compostela. La Coruña. Spain, La Coruña, Spain, ³⁵Rheumatology, Hospital de Cabueñes. Gijón. Spain, Gijón, Spain, ³⁶Ophthalmology, Hospital General Universitario de Valencia. Spain, Valencia, Spain, ³⁷Rheumatology, Hospital del Mar. Barcelona. Spain, Barcelona, Spain, ³⁸Hospital de Pontevedra. Pontevedra. Spain, Pontevedra, Spain, ³⁹Ophthalmology, Hospital de Pontevedra. Pontevedra. Spain, Pontevedra, Spain, ⁴⁰Rheumatology, Hospital de Sierrallana, Torrelavega. Cantabria. Spain, Torrelavega, Spain
Background/Purpose: Retinal vasculitis is a serious complication of uveitis due to Behçet’s disease (BD). The treatment is based on corticosteroids, conventional immunosuppressants (IS) and anti-TNF-α…
Abstract Number: 2270 • 2018 ACR/ARHP Annual Meeting
Treatment of Refractory Cystoid Macular Edema to Conventional Immunosuppressive Therapy: Tocilizumab Vs Anti-TNF-Alpha. Multicenter Study of 59 Patients
José Luis Martín-Varillas¹, Belén Atienza-Mateo¹, Vanesa Calvo-Río², Monica Calderón Goercke², Diana Prieto Peña², Rosalía Demetrio-Pablo³, Javier Loricera³, Eva Peña Sainz-Pardo³, M. Victoria Hernández⁴, Alfredo Adan⁵, Marina Mesquida⁵, Santos Insua⁶, Jose M Herreras⁷, Olga Maíz⁸, Ana Blanco⁹, Myriam Gandía¹⁰, David Diaz-Valle¹¹, Lucía Martínez-Costa¹², Elia Valls-Pascual¹², Gisela Díaz-Cordovés¹³, Manuel Díaz-Llopis¹⁴, Inmaculada Calvo¹⁵, Ignacio Torre-Salaberri¹⁶, Antonio Atanes¹⁷, Luis Francisco Linares¹⁸, Marisa Hernández¹⁹, Emma Beltrán²⁰, Miguel Cordero-Coma²¹, Elena Aurrecoechea²², Félix Francisco²³, Raquel Almodóvar González²⁴, Oscar Ruiz Moreno²⁵, Fernando Jiménez-Zorzo²⁶, Joan Miquel Nolla²⁷, Consuelo Modesto²⁸, Enar Pons¹, Miguel Angel González-Gay³ and Ricardo Blanco¹, ¹Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ²Rheumatology, Rheumatology. Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ³Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ⁴Rheumatology, Hospital Clinic. Barcelona. Spain, Barcelona, Spain, ⁵Hospital Clinic. Barcelona. Spain, Barcelona, Spain, ⁶Rheumatology, Hospital Universitario Santiago de Compostela. La Coruña. Spain, La Coruña, Spain, ⁷Ophthalmology, Hospital Universitario, IOBA. Valladolid. Spain, Valladolid, Spain, ⁸Hospital Universitario Donostia. San Sebastian. Spain, San Sebastián, Spain, ⁹Ophtamology, Hospital Universitario Donostia. San Sebastian. Spain, San Sebastian, Spain, ¹⁰Rheumatology, Hospital Puerta del Mar. Cádiz. Spain, Cádiz, Spain, ¹¹Hospital Clínico San Carlos. Madrid. Spain, Madrid, Spain, ¹²Hospital Universitario Doctor Peset. Valencia. Spain, Valencia, Spain, ¹³Rheumatology, Hospital Regional Universitario de Málaga. Spain, Málaga, Spain, ¹⁴Hospital Universitario La Fe. Valencia. Spain, Valencia, Spain, ¹⁵Hospital Universitario La Fe, Valencia, Spain, ¹⁶Rheumatology, Hospital Universitario de Basurto. Bilbao. Spain, Bilbao, Spain, ¹⁷Complejo Hospitalario Universitario A Coruña. Spain, A Coruna, Spain, ¹⁸Rheumatology, Hospital Virgen de la Arrixaca. Murcia. Spain, Murcia, Spain, ¹⁹Ophthalmology, Hospital General Universitario de Valencia. Spain, Valencia, Spain, ²⁰Rheumatology, Hospital del Mar. Barcelona. Spain, Barcelona, Spain, ²¹Ophthalmology, Hospital de León. Spain, León, Spain, ²²Rheumatology, Hospital de Sierrallana, Torrelavega. Cantabria. Spain, Torrelavega, Spain, ²³Rheumatology, Hospital Doctor Negrín. Las Palmas de Gran Canaria. Spain, Las Palmas de Gran Canaria, Spain, ²⁴Rheumatology, Hospital Universitario Fundación Alcorcón. Madrid. Spain, Madrid, Spain, ²⁵Ophthalmology and Rheumatology, Hospital Miguel Servet. Zaragoza. Spain, Zaragoza, Spain, ²⁶Hospital Miguel Servet. Zaragoza. Spain, Zaragoza, Spain, ²⁷Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain, ²⁸Hospital Universitari Vall d'Hebron. Barcelona. Spain, Barcenola, Spain
Background/Purpose: Cystoid macular edema (CME) is the main cause of irreversible visual loss in patients with uveitis. Our aim objective was to determine the efficacy…
Abstract Number: 2271 • 2018 ACR/ARHP Annual Meeting
Long-Term Efficacy and Safety of Adalimumab By Immunosuppressant Use in Patients with Non-Infectious Uveitis
Yan Guex-Crosier¹, C. Stephen Foster², Kei Nakai³, Hiroshi Goto⁴, Kevin Douglas⁵, Sophia Pathai⁶, Martina Kron⁷, Alexandra P. Song⁵, Joachim Van Calster⁸ and Alfredo Adan⁹, ¹Jules Gonin Eye Hospital, University of Lausanne, Lausanne, Switzerland, ²Massachusetts Eye Research and Surgery Institution (MERSI), Ocular Immunology & Uveitis Foundation (OIUF), Waltham, MA, USA and Harvard Medical School, Boston, MA, ³Yodogawa Christian Hospital, Osaka, Japan, ⁴Tokyo Medical University, Tokyo, Japan, ⁵AbbVie Inc., North Chicago, IL, ⁶AbbVie Ltd, Maidenhead, United Kingdom, ⁷AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany, ⁸University Hospitals Leuven, Leuven, Belgium, ⁹Hospital Clinic. Barcelona. Spain, Barcelona, Spain
Background/Purpose: To evaluate the long-term safety and efficacy of adalimumab in patients with non-infectious intermediate, posterior, or panuveitis, by immunosuppressant (IMM) use. Methods: Adult patients…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].